CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function

Production of CCL2 by Central Nervous System Cells Regulates Development of Murine Experimental Autoimmune Encephalomyelitis through the Recruitment of TNF- and iNOS-Expressing Macrophages and Myeloid Dendritic Cells

(2014) R.-N. E. Dogan et al.   JOURNAL OF IMMUNOLOGY

Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease

(2009) I. L. King et al.   BLOOD

Selective Expansion of the Monocytic Lineage Directed by Bacterial Infection

(2009) N. V. Serbina et al.   JOURNAL OF IMMUNOLOGY

A Novel Mechanism for CCR4 in the Regulation of Macrophage Activation in Bleomycin-Induced Pulmonary Fibrosis

(2008) Glenda Trujillo et al.   AMERICAN JOURNAL OF PATHOLOGY

CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling

(2008) Makoto Ishii et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis

(2008) Joanna B Tierney et al.   IMMUNOLOGY AND CELL BIOLOGY

Ly6c+“inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis

(2008) Daniel R. Getts et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation

(2008) Astrid E. Cardona et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Pharmacological Profile of JNJ-27141491 [(S)-3-[3,4-Difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl Acid Methyl Ester], as a Noncompetitive and Orally Active Antagonist of the Human Chemokine Receptor CCR2

(2008) M. Buntinx et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

MDC/CCL22 intrathecal levels in patients with multiple sclerosis

(2008) D. Galimberti et al.   Multiple Sclerosis Journal